BEAT BioTherapeutics
Bellevue, Washington, United States
About BEAT BioTherapeutics
BEAT BioTherapeutics (BEATBio) is a Seattle, WA based biotechnology company founded to develop novel therapies for heart disease. BEAT Bio’s first product is based on a fundamental discovery in cardiac muscle contraction and the development of a novel GeneTherapy to improve cardiac performance in the setting of heart failure.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $2.5M
- Funding stage: Seed
- Last round: Seed (Apr 2013)
- Website: beatbiotherapeutics.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Medical, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/beat-biotherapeutics-2502647 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.